endometrial cancer

Pharma

Keytruda follows GSK's PD-1 with 1L endometrial cancer win

Keytruda's and Jemperli's first-line endometrial cancer data will be carefully studied by industry watchers after GSK's recent head-to-head win.
Angus Liu Feb 3, 2023 10:42am

GSK's Jemperli targets broader endometrial cancer use

Dec 2, 2022 11:59am

Merck's Keytruda pressures GSK PD-1's limited living space

Mar 22, 2022 10:36am

Karyopharm hits FDA setback with Xpovio's cancer expansion bid

Mar 2, 2022 11:03am

Karyopharm plans FDA filing for Xpovio in endometrial cancer

Feb 9, 2022 8:46am

Keytruda-Lenvima combo gains FDA nod in endometrial cancer

Jul 22, 2021 11:52am